Page 6 - பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம் Today - Breaking & Trending Today

ENHERTU® Receives Prime Minister's Award from the Japan Techno-Economics Society

Press release content from Business Wire. The AP news staff was not involved in its creation.
ENHERTU® Receives Prime Minister’s Award from the Japan Techno-Economics Society
January 27, 2021 GMT
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that ENHERTU
® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate (ADC), received the Prime Minister’s Award at the 9 th Technology Management and Innovation Awards hosted by the Japan Techno-Economics Society (JATES).
The Technology Management and Innovation Awards were established in 2012 with the objective of contributing to the development of the nation’s economy, social changes, and the promotion of a global competitive edge by widely introducing technological innovations originating in Japan. This year marks the 9 th year of the award. ....

United States , Masashi Kawase , Daiichi Sankyo , Daiichi Sankyo Europe Gmb , Sunao Manabe , Don Murphy , Economics Society , Daiichi Sankyo Company , Daiichi Sankyo Inc , Clinical Development Program , Daiichi Sankyo Co Ltd , Technology Management , Daiichi Sankyo Group , Sankyo Company , Prime Minister , Innovation Awards , Japan Techno Economics Society , Representative Director , Interstitial Lung Disease , Development Program , Breakthrough Therapy Designation , Astrazeneca Collaboration , Safety Information , Lung Disease , Metastatic Gastric Cancer , Absolute Neutrophil Count ,

UPDATE: Sumitovant Biopharma Announces Myovant Sciences Positive One-Year Data from Phase 3 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
UPDATE: Sumitovant Biopharma Announces Myovant Sciences Positive One-Year Data from Phase 3 .
Sumitovant BiopharmaJanuary 26, 2021 GMT
NEW YORK, LONDON,, Jan. 26, 2021 (GLOBE NEWSWIRE) Sumitovant Biopharma Ltd., a majority shareholder of Myovant Sciences (NYSE: MYOV), announced today that Myovant Sciences’ Phase 3 SPIRIT long-term extension study of the investigational once-daily relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5 mg) in women with endometriosis reported clinically meaningful reductions in dysmenorrhea (menstrual pain) and non-menstrual pelvic pain over one year (52 weeks) with minimal and stable bone mineral density loss. The dat a are consistent with the efficacy and safety profile observed through 24 weeks in the Phase 3 SPIRIT 1 and SPIRIT 2 studies. These results will be included in the New Drug Applicat ....

New York , United States , City Of , United Kingdom , Sumitomo Dainippon Pharma , Sumitovant Biopharma , Mary Stutts Sumitovant Biopharma , Myrtle Potter , Juan Camilo Arjona Ferreira , Myovant Sciences Forward , American Society For Reproductive Medicine , Drug Administration , Myovant Sciences , Dainippon Pharmaceutical Co Ltd , Exchange Commission , Myovant Sciences Inc , European Union , Sumitomo Dainippon Pharma Co Ltd , Virtual Congress , Sumitomo Pharmaceuticals Co Ltd , Sumitovant Biopharma Ltd , Program In Endometriosis , Biopharma Ltd , Myovant Science Phase , New Drug Application , Chief Executive Officer ,

Challenge the stigma, pursue your right to health

20 January 202120 January 202120 January 2021
Adolescent girls and young women must boldly and unapologetically seek sexual and reproductive he
Adolescent girls and young women must boldly and unapologetically seek sexual and reproductive health and rights information and services. The stigma and harmful gender norms associated with sexual and reproductive health and rights are not going anywhere, says Nyasha Phanisa Sithole, a Zimbabwean sexual and reproductive health and rights leader.
“If you are afraid of stigma, then you will not be able to access these services because we are not going to have a stigma-free environment any time soon,” she says.
Working as a sexual and reproductive health and rights advocate and a regional lead for young women’s advocacy, leadership and training at the Athena Network, Ms Sithole believes everyone has a role to play in changing the status quo and influencing decision-making. ....

Mashonaland East , Nyasha Phanisa Sithole , United Nations Population Fund , Athena Network , Prevention Coalition , What Girls Want , Feature Story , Covid 19 , Sexual And Reproductive Health , Stigma And Discrimination , Women And Girls , Young People , East And Southern Africa , மஷோனலண்ட் கிழக்கு , ஒன்றுபட்டது நாடுகள் பாப்யுலேஶந் நிதி , அதீனா வலைப்பின்னல் , ப்ரெவெந்ஶந் கூட்டணி , என்ன பெண்கள் வேண்டும் , அம்சம் கதை , பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம் , களங்கம் மற்றும் பாகுபாடு , பெண்கள் மற்றும் பெண்கள் , இளம் மக்கள் ,

ENHERTU® Approved in the U.S. for the Treatment of Patients With Previously Treated HER2 Positive Advanced Gastric Cancer

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

Baylor University , United States , South Korea , Dave Fredrickson , Ronan Kelly , Daiichi Sankyo , Ww Caruth Jr , Antoine Yver , Daiichi Sankyo Company , American Society Of Clinical Oncology , Daiichi Sankyo Inc , Drug Administration , Clinical Development Program , Charlesa Sammons Cancer Center , Oncology Research , European Medicines Agency , Immunology At Baylor University Medical Center , Sankyo Company , Conveyor Belt , Cancer Center , Baylor University Medical Center , Clinical Oncology , New England Journal , Executive Vice President , Global Head , Oncology Business Unit ,

Syphilis Rapid Test Kit Market To Witness A Pronounce Growth With CAGR % With Top Key Players 2022-2031

Press release content from Wired Release. The AP news staff was not involved in its creation.
Syphilis Rapid Test Kit Market To Witness A Pronounce Growth With CAGR % With Top Key Players 2022-2031
January 15, 2021 GMT
Pune, Maharashtra, India, January 15 2021 (Wiredrelease) Prudour Pvt. Ltd :The research study on global Syphilis Rapid Test Kit market presents an extensive analysis of current Syphilis Rapid Test Kit trends, market size, drivers, Syphilis Rapid Test Kit opportunities, challenges, and problems as well as key Syphilis Rapid Test Kit market segments. Further, in the Syphilis Rapid Test Kit market report,various definitions and classification of the Syphilis Rapid Test Kit industry, applications and chain structure are discussed. In continuation with this data Syphilis Rapid Test Kit report also covers the marketing strategies followed by Syphilis Rapid Test Kit players, distributors analysis, Syphilis Rapid Test Kit marketing channels, potential buyers and ....

New York , United States , United Kingdom , South Africa , Saudi Arabia , South Korea , Abbott Alere , Wantai Biopharm , Market Development , Beckman Coulter , Elitech Group , Product Development Innovation , Wiredrelease News Department , Trinity Biotech , Syphilis Rapid Test Kit , Syphilis Rapid Test Kit Market , Syphilis Rapid Test , Syphilis Rapid Test Kit Market Segmentation , Rapid Test Kit , Leading Playersinvolved , North America , South America , Middle East , Korea India , Asia Pacific , Rotary Motion Control Valve ,